Obinutuzumab in Rituximab-Intolerant Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Patients

• Jolijn R. van Leeuwen,
• Obbo W. Bredewold,
• Ton J. Rabelink,
• Y.K.Onno Teng

Affiliations

Jolijn R. van Leeuwen

Center of Expertise for Lupus-, Vasculitis- and Complement-Mediated Systemic Diseases, Department of Internal Medicine - Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands

Obbo W. Bredewold

Center of Expertise for Lupus-, Vasculitis- and Complement-Mediated Systemic Diseases, Department of Internal Medicine - Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands

Ton J. Rabelink

Center of Expertise for Lupus-, Vasculitis- and Complement-Mediated Systemic Diseases, Department of Internal Medicine - Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands

Y.K.Onno Teng

Center of Expertise for Lupus-, Vasculitis- and Complement-Mediated Systemic Diseases, Department of Internal Medicine - Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands; Correspondence:Y. K. Onno Teng, Department of Nephrology, Leiden University Medical Center, (LUMC) P.O. Box 9600, 2300 RC Leiden, The Netherlands.